Fifth Third Bancorp’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $39.5M | Buy |
88,499
+66,341
| +299% | +$30.9M | 0.07% | 207 |
|
|
2025
Q4 | $10M | Sell |
22,158
-65
| -0.3% | -$28K | 0.03% | 248 |
|
|
2025
Q3 | $8.7M | Sell |
22,223
-2,001
| -8% | -$836K | 0.03% | 259 |
|
|
2025
Q2 | $10.8M | Sell |
24,224
-1,585
| -6% | -$730K | 0.04% | 237 |
|
|
2025
Q1 | $12.5M | Sell |
25,809
-294
| -1% | -$137K | 0.05% | 221 |
|
|
2024
Q4 | $10.5M | Sell |
26,103
-937
| -3% | -$434K | 0.04% | 236 |
|
|
2024
Q3 | $12.6M | Buy |
27,040
+418
| +2% | +$201K | 0.05% | 221 |
|
|
2024
Q2 | $12.5M | Sell |
26,622
-119
| -0.4% | -$51.7K | 0.05% | 219 |
|
|
2024
Q1 | $11.2M | Sell |
26,741
-316
| -1% | -$134K | 0.04% | 231 |
|
|
2023
Q4 | $11M | Sell |
27,057
-478
| -2% | -$177K | 0.05% | 229 |
|
|
2023
Q3 | $9.58M | Buy |
27,535
+60
| +0.2% | +$21K | 0.04% | 235 |
|
|
2023
Q2 | $9.67M | Sell |
27,475
-1,579
| -5% | -$532K | 0.04% | 243 |
|
|
2023
Q1 | $9.15M | Buy |
29,054
+2,580
| +10% | +$774K | 0.04% | 253 |
|
|
2022
Q4 | $7.65M | Buy |
26,474
+1,387
| +6% | +$423K | 0.04% | 266 |
|
|
2022
Q3 | $7.26M | Buy |
25,087
+2,716
| +12% | +$781K | 0.04% | 269 |
|
|
2022
Q2 | $6.3M | Buy |
22,371
+2,401
| +12% | +$643K | 0.03% | 292 |
|
|
2022
Q1 | $5.21M | Buy |
19,970
+4,047
| +25% | +$960K | 0.02% | 337 |
|
|
2021
Q4 | $3.5M | Sell |
15,923
-1,130
| -7% | -$220K | 0.01% | 389 |
|
|
2021
Q3 | $3.09M | Sell |
17,053
-4,899
| -22% | -$957K | 0.01% | 400 |
|
|
2021
Q2 | $4.43M | Sell |
21,952
-54,768
| -71% | -$11.5M | 0.02% | 355 |
|
|
2021
Q1 | $16.5M | Sell |
76,720
-9,848
| -11% | -$2.16M | 0.08% | 201 |
|
|
2020
Q4 | $20.5M | Buy |
86,568
+30,612
| +55% | +$7.02M | 0.1% | 175 |
|
|
2020
Q3 | $15.2M | Buy |
55,956
+15,863
| +40% | +$4.38M | 0.08% | 178 |
|
|
2020
Q2 | $11.6M | Buy |
40,093
+34,496
| +616% | +$9.35M | 0.07% | 202 |
|
|
2020
Q1 | $1.33M | Buy |
5,597
+95
| +2% | +$21.8K | 0.01% | 433 |
|
|
2019
Q4 | $1.21M | Buy |
5,502
+188
| +4% | +$38K | 0.01% | 502 |
|
|
2019
Q3 | $900K | Sell |
5,314
-927
| -15% | -$164K | 0.01% | 533 |
|
|
2019
Q2 | $1.14M | Buy |
6,241
+30
| +0.5% | +$5.25K | 0.01% | 483 |
|
|
2019
Q1 | $1.14M | Buy |
6,211
+1,058
| +21% | +$195K | 0.01% | 469 |
|
|
2018
Q4 | $854K | Buy |
5,153
+55
| +1% | +$9.53K | 0.01% | 504 |
|
|
2018
Q3 | $983K | Buy |
5,098
+243
| +5% | +$43.3K | 0.01% | 508 |
|
|
2018
Q2 | $825K | Buy |
4,855
+266
| +6% | +$41.2K | 0.01% | 556 |
|
|
2018
Q1 | $748K | Buy |
4,589
+4,115
| +868% | +$672K | 0.01% | 562 |
|
|
2017
Q4 | $71K | Buy |
474
+77
| +19% | +$11.4K | ﹤0.01% | 1165 |
|
|
2017
Q3 | $60K | Buy |
397
+123
| +45% | +$18.5K | ﹤0.01% | 1242 |
|
|
2017
Q2 | $35K | Buy |
274
+33
| +14% | +$3.97K | ﹤0.01% | 1398 |
|
|
2017
Q1 | $26K | Buy |
241
+11
| +5% | +$968 | ﹤0.01% | 1505 |
|
|
2016
Q4 | $17K | Sell |
230
-212
| -48% | -$17.3K | ﹤0.01% | 1658 |
|
|
2016
Q3 | $39K | Sell |
442
-142
| -24% | -$13.4K | ﹤0.01% | 1411 |
|
|
2016
Q2 | $50K | Sell |
584
-483
| -45% | -$41.7K | ﹤0.01% | 1298 |
|
|
2016
Q1 | $85K | Sell |
1,067
-1,025
| -49% | -$92.7K | ﹤0.01% | 1144 |
|
|
2015
Q4 | $263K | Buy |
2,092
+215
| +11% | +$26K | ﹤0.01% | 884 |
|
|
2015
Q3 | $195K | Sell |
1,877
-326
| -15% | -$41.9K | ﹤0.01% | 974 |
|
|
2015
Q2 | $272K | Buy |
2,203
+773
| +54% | +$97.4K | ﹤0.01% | 903 |
|
|
2015
Q1 | $169K | Buy |
1,430
+352
| +33% | +$42.2K | ﹤0.01% | 1035 |
|
|
2014
Q4 | $128K | Buy |
1,078
+98
| +10% | +$11K | ﹤0.01% | 1083 |
|
|
2014
Q3 | $110K | Buy |
980
+118
| +14% | +$11.2K | ﹤0.01% | 1143 |
|
|
2014
Q2 | $82K | Buy |
862
+24
| +3% | +$1.68K | ﹤0.01% | 1246 |
|
|
2014
Q1 | $59K | Sell |
838
-87
| -9% | -$6.89K | ﹤0.01% | 1354 |
|
|
2013
Q4 | $69K | Buy |
925
+362
| +64% | +$25.2K | ﹤0.01% | 1196 |
|
|
2013
Q3 | $43K | Sell |
563
-228
| -29% | -$18.1K | ﹤0.01% | 1369 |
|
|
2013
Q2 | $63K | Buy |
+791
| New | +$58.3K | ﹤0.01% | 1216 |
|
Other funds holding VRTX
VCM
VPM
Fifth Third Bancorp's VRTX Position: Q1 2026 in Review
Fifth Third Bancorp increased its Vertex Pharmaceuticals (VRTX) stake by 299% in Q1 2026, buying an estimated $30.9M and bringing the position to 88,499 shares worth $39.5M. The position accounts for 0.07% of the portfolio, ranked #207.
Fifth Third Bancorp first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Fifth Third Bancorp held 88,499 shares of Vertex Pharmaceuticals worth $39.5M as of Q1 2026.
- Fifth Third Bancorp bought 66,341 Vertex Pharmaceuticals shares in Q1 2026, an estimated $30.9M.
- Vertex Pharmaceuticals made up 0.07% of Fifth Third Bancorp's portfolio in Q1 2026, its #207 holding.
- Fifth Third Bancorp first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.